Literature DB >> 9231418

A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg.

J L Koeck1, G Arlet, A Philippon, S Basmaciogullari, H V Thien, Y Buisson, J D Cavallo.   

Abstract

Multiresistance to antibiotics including beta-lactams, e.g. cefoxitin, was transferred by conjugation to Escherichia coli strain C1a from a clinical isolate of Salmonella senftenberg recovered from stools of an Algerian child. The susceptibility pattern to beta-lactams was similar to the profile mediated by an AmpC-type beta-lactamase. By biochemical analysis, typical AmpC-type enzyme substrate and inhibition profiles were obtained. Finally, an ampC plasmid-encoded beta-lactamase gene was cloned and sequenced. Its deduced amino acid sequence confirmed its identity as a class C beta-lactamase. It showed 99.5% sequence identity with the plasmid-mediated beta-lactamase CMY-2. The differences in the amino acid sequences of the two enzymes were located in the signal peptide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231418     DOI: 10.1111/j.1574-6968.1997.tb10436.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  40 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.

Authors:  A Carattoli; F Tosini; W P Giles; M E Rupp; S H Hinrichs; F J Angulo; T J Barrett; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.

Authors:  P D Stapleton; K P Shannon; G L French
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.

Authors:  R A Powers; J Blázquez; G S Weston; M I Morosini; F Baquero; B K Shoichet
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

5.  First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test.

Authors:  Etienne Ruppé; Philippe Bidet; Charlotte Verdet; Guillaume Arlet; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

6.  Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia.

Authors:  Olfa Bouallègue-Godet; Youssef Ben Salem; Laëtitia Fabre; Marie Demartin; Patrick A D Grimont; Ridha Mzoughi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract.

Authors:  C Poppe; L C Martin; C L Gyles; R Reid-Smith; P Boerlin; S A McEwen; J F Prescott; K R Forward
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

Review 8.  Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Chishih Chu
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.

Authors:  F Freitas; E Machado; T G Ribeiro; Â Novais; L Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-07       Impact factor: 3.267

10.  Molecular epidemiology and characterization of plasmid-encoded beta-lactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broad-spectrum cephalosporins.

Authors:  Abdoulaye Makanera; Guillaume Arlet; Valérie Gautier; Mohamed Manai
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.